Adis International Ltd

SHERPA: Unknown

People

  1. Boelens
    Boelens
  2. Gulati
    Gulati
  3. Hudis
    Hudis
  4. Geller
    Geller
  5. Jakubowski
    Jakubowski
  6. Lichtman
    Lichtman
  7. Moryl
    Moryl
  8. Motzer
    Motzer
  9. Norton
    Norton
  10. Panageas
    Panageas

Groups

  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (12)
  3. Survivorship Research (12)
  4. Dermatology Service (7)
  5. Dermatology (6)
  6. Division of Subspecialty Medicine (6)
  7. Breast Medicine Service (5)
  8. Sloan Kettering Institute Postdocs (5)
  9. Center for Hematologic Malignancies (4)
  10. GME, Medicine (4)
Search Within
Formats
  1. Journal Article (33)
  2. Review (11)
  3. Research Letter (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (20)
  2. Solid Tumor Oncology Division (12)
  3. Survivorship Research (12)
  4. Dermatology Service (7)
  5. Dermatology (6)
  6. Division of Subspecialty Medicine (6)

More Groups

People
  1. Mario Lacouture (4)
  2. Amitabh Gulati (3)
  3. Clifford Hudis (3)
  4. Jaap Jan Boelens (3)
  5. Ann Jakubowski (2)
  6. Anthony Rossi (2)

More People

Years
  1. 2024 (4)
  2. 2023 (2)
  3. 2022 (5)
  4. 2021 (3)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Drugs (15)
  2. American Journal of Clinical Dermatology (11)
  3. Drugs & Aging (6)
  4. Clinical Pharmacokinetics (5)
  5. CNS Drugs (4)
  6. Clinical Immunotherapeutics (2)

More Publications

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Current treatment of chronic lymphocytic leukemia: The diminishing role of chemoimmunotherapy
    Review

    Roeker, L. E.; Thompson, M.; Mato, A. R.
    Drugs (2022)

    Fulltext@MSK | Save
  • Targeted agents for HER2-positive breast cancer: Optimal use in older patients
    Review

    Singh, J. C.; Lichtman, S. M.
    Drugs & Aging (2021)

    Fulltext@MSK | Save
  • Failure of SCS MR-conditional modes due to high impedance: A review of literature and case series
    Journal Article

    Jotwani, R.; Abd-Elsayed, A.; Villegas, K.; Shakil, A.; Gulati, A.; Sayed, D.; Lam, C.; Mehta, N.
    Pain and Therapy (2021)

    Fulltext@MSK | Save
  • Hospital length of stay for patients with severe COVID-19: Implications for remdesivir’s value
    Research Letter

    Anderson, M. R.; Bach, P. B.; Baldwin, M. R.
    PharmacoEconomics - Open (2021)

    Fulltext@MSK | Save
  • When is it OK to stop anti-programmed death 1 receptor (PD-1) therapy in metastatic melanoma?
    Review

    Banks, L. B.; Sullivan, R. J.
    American Journal of Clinical Dermatology (2020)

    Fulltext@MSK | Save
  • New treatment strategies for metastatic pancreatic ductal adenocarcinoma
    Review

    Singh, R. R.; O’Reilly, E. M.
    Drugs (2020)

    Fulltext@MSK | Save
  • Population pharmacokinetics of alemtuzumab (Campath) in pediatric hematopoietic cell transplantation: Towards individualized dosing to improve outcome
    Journal Article

    Admiraal, R.; Jol-van der Zijde, C. M.; Furtado Silva, J. M.; Knibbe, C. A. J.; Lankester, A. C.; Boelens, J. J.; Hale, G.; Etuk, A.; Wilson, M.; Adams, S.; more...
    Clinical Pharmacokinetics (2019)

    Fulltext@MSK | Save
  • Population pharmacokinetics of fludarabine in children and adults during conditioning prior to allogeneic hematopoietic cell transplantation
    Journal Article

    Langenhorst, J. B.; Dorlo, T. P. C.; van Maarseveen, E. M.; Nierkens, S.; Kuball, J.; Boelens, J. J.; van Kesteren, C.; Huitema, A. D. R.
    Clinical Pharmacokinetics (2019)

    Fulltext@MSK | Save
  • Toxic side effects of targeted therapies and immunotherapies affecting the skin, oral mucosa, hair, and nails
    Conference Paper

    Lacouture, M.; Sibaud, V.
    Adis International Ltd (2018)

    Fulltext@MSK | Save
  • Treating chronic pain: An overview of clinical studies centered on the buprenorphine option
    Journal Article

    Davis, M. P.; Pasternak, G.; Behm, B.
    Drugs (2018)

    Fulltext@MSK | Save

    • Adis International Ltd – authorized name for: